BioSpace News Archive

Novavax, Inc. today announced that its representatives will share data from its RSV F vaccine program via oral and poster presentations at IDWeek 2018 in San Francisco, California, taking place October 3-7 and at the 11th International Respiratory Syncytial Virus Symposium in Asheville, North Carolina, taking place October 31-November 4.

Cytokinetics, Incorporated today announced that it will host an R&D Day on Tuesday, October 16, 2018 from 8:30 AM to 12:30 PM ET at the Parker New York Hotel in New York City.

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced that Jay Hagan, President and Chief Executive Officer of Regulus, will participate in a fireside chat at the Chardan Genetic Medicines Conference in New York City on Tuesday, October 9, 2018.

GenMark Diagnostics, Inc. today announced the submission of two additional ePlex Blood Culture Identification Panels

CytoSen Therapeutics and KBI Biopharma today announced a strategic partnership to manufacture therapeutic Natural Killer (NK) cells using a proprietary and scalable, closed system manufacturing process.

Pain Therapeutics, Inc. today announced that it will host a live conference call to provide a strategic update regarding its business, its science and its pipeline.

Epizyme, Inc. today announced the pricing of an underwritten public offering of 8,333,334 shares of its common stock at a price of $9.00 per share, before underwriting discounts.

This October, H&M is launching the first collection of bras for breast cancer survivors with inspiration from one of their employees while supporting the American Cancer Society (ACS) as they unite in the fight against breast cancer.

Recovery Centers of America (RCA) Alumni Association, a non-profit 501c3, invites Maryland and Delaware communities for Fall Fest 2018, celebrating the two-year anniversary of providing high-quality, comprehensive addiction treatment services in Cecil County.

VenatoRx Pharmaceuticals will feature its lead clinical antibacterial candidate, cefepime/VNRX-5133, at IDWeek 2018 which is taking place in San Francisco, CA this week from October 3-7, 2018.